Spence M R, Williams R, DiGregorio G J, Kirby-McDonnell A, Polansky M
Department of Obstetrics and Gynecology, Hahnemann University School of Medicine, Philadelphia, PA.
Obstet Gynecol. 1991 Sep;78(3 Pt 1):326-9.
We conducted urine screening for cocaine metabolite in 500 consecutive women admitted to a labor and delivery unit. The pregnancy outcome of 411 of the women was determined at that admission. The prevalence of cocaine-positive urines was 15.3% (95% confidence interval 11.8-18.8%). A subset of this population that had not received prenatal care had a prevalence of 62% (95% confidence interval 47.2-76.6%). Women with positive urines were almost four times more likely to have preterm labor and over twice as likely to deliver a premature infant or one with a 1-minute Apgar score of 6 or lower. Our findings support the concept that urine drug screening for cocaine and/or other drugs of abuse should be considered in patients who present with no prenatal care, premature labor, premature delivery, and delivery of an infant with a 1-minute Apgar score of 6 or less. This strategy may enable us to identify and bring to therapy a population of women that could potentially go unrecognized.
我们对入住分娩单元的500名连续产妇进行了可卡因代谢物的尿液筛查。其中411名女性在入院时的妊娠结局得以确定。可卡因阳性尿液的患病率为15.3%(95%置信区间11.8 - 18.8%)。该人群中未接受产前护理的一个亚组患病率为62%(95%置信区间47.2 - 76.6%)。尿液呈阳性的女性发生早产的可能性几乎是四倍,分娩早产儿或1分钟阿氏评分≤6分婴儿的可能性是两倍多。我们的研究结果支持这样一个概念,即对于未接受产前护理、早产、早产分娩以及分娩1分钟阿氏评分≤6分婴儿的患者,应考虑进行可卡因和/或其他滥用药物的尿液药物筛查。这一策略可能使我们能够识别并治疗一群可能未被发现的女性。